OpenAI launches GPT-5.3-Codex with faster coding, stronger reasoning, and higher benchmark accuracy—plus API access soon.

Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...

Over the holidays, Alex Lieberman had an idea: What if he could create Spotify “Wrapped” for his text messages? Without writing a single line of code, Lieberman, a co-founder of the media outlet ...

Chai Discovery’s AI platform, including purpose-built custom models, will be deployed to accelerate the discovery of next-generation therapeutics SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI ...

The franchise's success reflects the growing size – and evolving nature – of Japan’s anime industry in recent years.

When the creator of the world's most advanced coding agent speaks, Silicon Valley doesn't just listen — it takes notes. "If you're not reading the Claude Code best practices straight from its creator, ...

Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a $1.3 billion valuation on Monday. The round was led by General Catalyst and Oak HC/FT, the ...

Chai Discovery Inc., a startup using artificial intelligence to accelerate drug development, today announced that it has closed a $130 million funding round led by Oak HC/FT and General Catalyst. The ...

Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to further energize development of its “computer-aided design suite” for new ...